Key result
Angiopoietins are essential in maintaining vascular homeostasis, and therapies targeting the angiopoietin-Tie2 pathway, such as faricimab, show promising efficacy for diabetic retinal diseases.
Why the study?
Diabetic retinopathy is a frequent complication of poorly controlled diabetes whose pathogenesis remains only partially understood.
Design
Review
Authors
Loading...
May support angiopoietin-targeted therapies in diabetic retinopathy; leaves open confirmation in larger trials.
Angiopoietins play a crucial role in the pathogenesis of diabetic retinopathy, making them a promising therapeutic target.
Collazos-Alemán et al. (2022) conducted a review in Neovascular Diabetes-Related Retinal Diseases (Diabetic Retinopathy, Diabetic Macular Edema). Angiopoietin-targeted therapies (e.g., Faricimab) was evaluated. Angiopoietins are essential in maintaining vascular homeostasis, and therapies targeting the angiopoietin-Tie2 pathway, such as faricimab, show promising efficacy for diabetic retinal diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: